ORTEXORTEX News
Tracking VLTO? Get live short interest, options flow, and signals on ORTEX.Sign up free →
VL
Earnings PreviewVLTO

Veralto Shorts Edge Up Into Earnings, But Borrow Market Stays Loose

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 26 Oct 2026, 04:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Short sellers have added modestly to positions in VLTO over the past week, with short interest climbing 3.6% to roughly 5.9 million shares, equal to 2.4% of the free float. That is a low absolute level, and the direction of travel is recent and tentative rather than sustained: the position peaked above 7.6 million shares at the end of September before retreating sharply through early October.

The borrow market tells a story of plentiful supply despite that week-on-week uptick. Availability remains extraordinarily loose at 3,014%, meaning there are roughly 30 shares available to lend for every one already borrowed. That ratio has tightened from above 6,500% earlier in October, but it is still far above the 52-week low of just under 1,050% hit on September 30. Borrowing costs reflect the same comfort: the cost-to-borrow has edged up about 10% on the week to 0.52%, but in absolute terms that remains near zero. The recent tightening in availability looks mechanical, consistent with quarter-end flows reversing, rather than a structural shift in bearish conviction.

The stock itself gained 3.3% on the week to $104.33, a solid move in isolation but trailing several close peers: WCN rose 11.1% and TTEK gained 6.5% over the same period. The options market has shifted slightly more defensive into the print. The put/call ratio is running at 0.86, above its 20-day average of 0.67, though the z-score of under one standard deviation means this is a mild lean rather than an alarm. The 52-week range for the PCR runs from 0.03 to 13.0, so the current reading sits far from genuine distress.

Analysts are divided on how much runway remains at the current price. The consensus mean target of $114 implies about 9% upside from Friday's close. The constructive camp points to 6.9% North American core sales growth and 5.1% organic revenue gains, with management having guided for around 30 basis points of operating margin expansion in the fourth quarter. Skeptics note that adjusted operating margins already slipped 10 basis points year-on-year to 23.9% in the most recent period, and that the shares trade at a slight discount to environmental services peers without an obvious rerating catalyst in the near term. The most recent analyst action of note came from UBS on October 5, where the firm raised its target from $104 to $106 while keeping a Neutral rating, essentially acknowledging the stock has moved but declining to endorse further gains.

One institutional flow worth flagging: T. Rowe Price added 5.7 million shares in the quarter ended September 30, a material increase that lifts its reported stake to 5.9% of shares outstanding. BlackRock and Vanguard also added incrementally over the same period. No 13D activist filings are on the register, and all passive holders are filing on Schedule 13G. CEO Jennifer Honeycutt's recent open-market activity consists entirely of prearranged 10b5-1 plan transactions, option exercises paired with same-day sales, which carry limited signal value.

Wednesday's print will test whether Veralto can sustain the organic growth rate that has driven the stock's 8.9% one-month gain while showing that the margin slippage of recent quarters has stabilised rather than deepened.

Stocks in this article

See the live data behind this article on ORTEX.

Open VLTO on ORTEX →

How this article was generated

Generated
26 Oct 2026, 04:33
Data as of
26 Oct 2026, 04:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.